Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvalent, Inc. Director's Dealing 2023

Sep 19, 2023

30903_dirs_2023-09-19_31769a5a-46cc-477e-96a4-16280cc01c6d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2023-09-15

Reporting Person: Miller Deborah Ann (Chief Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-15 Class A Common Stock M 2000 $6.89 Acquired 2000 Direct
2023-09-15 Class A Common Stock S 1244 $47.43 Disposed 756 Direct
2023-09-15 Class A Common Stock S 756 $47.99 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-15 Stock Option (Right to Buy) $6.89 M 2000 Disposed 2031-04-29 Class A Common Stock (2000) Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.84 to $47.82, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.88 to $48.30, inclusive.

F4: The shares underlying this option vest as follows: 25% of the shares vested on April 15, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.